World Class Faculty & Research
Risk Matters: Tariff Risks and Opportunities for Pharma Manufacturers
Clifford Rossi, Academic Director of the Smith Enterprise Risk Consortium, warns that pharma tariffs could disrupt supply chains, raise costs, and pressure manufacturers, especially generics. Adopting continuous manufacturing (CM) offers efficiency gains, balancing risk mitigation with strategic investment.